Back to FDA Applications sponsored by SENTYNL THERAPS INC

FDA Drug Application 022510 by SENTYNL THERAPS INC

Application Number022510
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP01/7/2011N27506000 1/10/2011
AP01/7/2011N27517000 1/13/2011
AP01/7/2011N27521000REMS 1/14/2011
AP01/7/2011N27533000 1/14/2011
AP01/7/2011N30470000 11/2/2011
AP01/7/2011N30472000 11/2/2011
AP012/28/2011SLR31328003 1/3/2012
AP012/28/2011SLR31365003 1/6/2012
AP06/5/2012SLR32852005 6/7/2012
AP06/5/2012SLR32885005 6/11/2012
AP011/7/2013SE837788007 11/12/2013
AP07/26/2013SLR36644010 7/30/2013
AP07/26/2013SLR36653010 7/30/2013
AP011/4/2014SLR40953013 12/24/2014
AP011/4/2014SLR40964013 11/7/2014
AP012/24/2014S41451014 12/30/2014

Back to FDA Applications sponsored by SENTYNL THERAPS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.